Stock News

$EIGR Stock Soar After Eiger’s Single-dose COVID-19 Reduced Risk of Hospitalization News

$EIGR Stock Soar After Eiger’s Single-dose COVID-19 Reduced Risk of Hospitalization News

Eiger BioPharmaceuticals announced, “Peginterferon Lambda (Lambda) significantly reduced the risk of COVID-19-related hospitalizations or emergency room visits greater than six hours by 50% (primary endpoint) and death by 60% in the Phase 3 TOGETHER study, a multi-center, randomized, double-blind, placebo-controlled study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness.”

EIGR STOCK UPDATE:

Wonder which online trading app would be easy and rewarding, also let you trade us pre market, day trading, Nasdaq index futures, and many more with an advanced trading chart? Join Moomoo and get up to 5 free stocks worth from $3 up to $3,500 each.

SIGN UP TO THIS SITE FOR FREE – Receive Daily Short Squeeze Email Updates

Sponsered: CapitalOne Silver Credit Card is giving a $200 sign-up bonus after you spend $500 in the first 3 months. This card is the most recommended for everyday spending, Earn unlimited 1.5% cash back on every purchase, with no annual fees. If you think you will spend $500 in 3 months, this might be a great card for you to start, and get that $200 sign-up bonus.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Welcome to The Finance Headline

Adblocker Detected! Please turn off your adblocker extension app to continue reading the articles/finance news. With your support, The Finance Headline is able to provide free resources.